Overall rank by patents
#5,437
Across all tracked assignees
USPTO PatentsView assignee record — 63 granted patents across 77 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F03G (SPRING, WEIGHT, INERTIA OR LIKE MOTORS; MECHANICAL-POWER PRODUCING DEVICES OR MECHANISMS, NOT OTHERWISE PROVIDED FOR OR USING ENERGY SOURCES NOT OTHERWISE PROVIDED FOR).
Exergyn, Ltd. has been granted 63 US utility patents between 2015 and 2025, placing Exergyn, Ltd. at rank #5,437 across all assignees tracked by PlainPatent. This portfolio spans 77 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.3 claims per patent with primary concentration in F03G (SPRING, WEIGHT, INERTIA OR LIKE MOTORS; MECHANICAL-POWER PRODUCING DEVICES OR MECHANISMS, NOT OTHERWISE PROVIDED FOR OR USING ENERGY SOURCES NOT OTHERWISE PROVIDED FOR). As a Foreign Corporation, Exergyn, Ltd. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 55.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 36 grants, compared with 27 in the 2015–2019 window — a +33% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Exergyn, Ltd.'s 11.3 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 77 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Exergyn, Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
International Business Machines Corporation
72,926 patents
Canon Kabushiki Kaisha
34,378 patents
LG ELECTRONICS INC.
32,607 patents
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
Apple Inc.
30,560 patents
QUALCOMM Incorporated
30,354 patents
Intel Corporation
27,498 patents
Exergyn, Ltd.
63 patents
What this shows Exergyn holds 63 patents — placing it at rank #5,437 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 4.8% |
| 2016 | 6 | 9.5% |
| 2017 | 3 | 4.8% |
| 2018 | 9 | 14.3% |
| 2019 | 6 | 9.5% |
| 2020 | 3 | 4.8% |
| 2021 | 7 | 11.1% |
| 2022 | 5 | 7.9% |
| 2023 | 10 | 15.9% |
| 2024 | 7 | 11.1% |
| 2025 | 4 | 6.3% |
Top 15 of 77 technology areas
Overall rank by patents
#5,437
Across all tracked assignees
55.3 out of 100
Exergyn, Ltd.'s primary CPC class — all holders and yearly trends
See where Exergyn, Ltd. ranks among the largest US patent assignees
Browse every CPC technology area by patent activity
The four dimensions behind the Innovation Score
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.